TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis

This study, called TREATgermany, is creating a national registry in Germany for people who have moderate-to-severe eczema, also known as atopic dermatitis. Eczema is a common skin condition that can affect people of all ages, from babies and children to adults. When eczema is moderate to severe, it means that creams and lotions might not be enough to control it well, and people might need stronger medicines that affect the whole body, or special light treatments. The goal of this registry is to gather a lot of practical, real-world information about how people with this type of eczema are being treated and how their health changes over many months.

Even though many treatments exist, doctors don't always have clear, long-term information about which ones work best for whom, especially in children and teenagers. This registry will help fill these gaps by tracking how effective different treatments are in everyday medical care, looking at things like how much the eczema improves, how it affects a person's daily life, and any other health conditions they might have. The study will also help prepare for new medications that are expected to become available for younger patients in the coming years, by providing important background information.

In simple terms, TREATgermany won't be giving anyone new medicines or treatments. Instead, it's like keeping a very detailed diary of how people with eczema are cared for by their own doctors. This information will then be used to help doctors and healthcare providers make better decisions about treatment, improve guidelines, and ensure that people with eczema get the best possible care, tailored to their individual needs.